Next report date
Report period
H2 2024
EPS estimate
−0.88USD
Revenue estimate
—
−2.3520USD
−21.42 MUSD
14.83 KUSD
About Bionomics Limited - American Depository Shares
Sector
CEO
Spyridon Papapetropoulos
Headquarters
Eastwood
Website
Founded
1996
FIGI
BBG013QG2041
Bionomics Ltd. is a clinical stage biopharmaceutical company. It engages in the development of novel drug candidates focused on the treatment of serious central nervous system disorders. Its lead product candidate is BNC210. The company was founded in 1996 and is headquartered in Eastwood, Australia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
